
HLB Therapeutics Co.,Ltd. — Investor Relations & Filings
HLB Therapeutics Co., Ltd. is a biopharmaceutical company specializing in the development of innovative, first-in-class drugs for rare and intractable diseases. The company's clinical-stage pipeline focuses on addressing unmet medical needs in ophthalmology and oncology. Key development programs include RGN-259, a therapeutic agent for Dry Eye Disease and Neurotrophic Keratopathy, and OKN-007 for the treatment of Glioblastoma Multiforme. Additionally, the company is advancing a Natural Killer (NK) cell therapy through late-stage clinical trials to provide new therapeutic options for patients.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 주식등의대량보유상황보고서(일반) | 2026-06-02 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 주식등의대량보유상황보고서(일반) | 2026-04-21 | Korean | |
| 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-01 | Korean | |
| 정기주주총회결과 | 2026-03-27 | Korean | |
| 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47927812 | 주식등의대량보유상황보고서(일반) | 2026-06-02 | Korean | ||
| 46354519 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34698114 | 주식등의대량보유상황보고서(일반) | 2026-04-21 | Korean | ||
| 33134768 | 전환사채(해외전환사채포함)발행후만기전사채취득 | 2026-04-01 | Korean | ||
| 33058879 | 정기주주총회결과 | 2026-03-27 | Korean | ||
| 33058873 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-27 | Korean | ||
| 33058854 | 본점소재지변경 | 2026-03-27 | Korean | ||
| 33038158 | 기업설명회(IR)개최 | 2026-03-25 | Korean | ||
| 33038143 | 기업설명회(IR)개최 | 2026-03-25 | Korean | ||
| 32985405 | 감사보고서제출 | 2026-03-19 | Korean | ||
| 32985399 | 사업보고서 (2025.12) | 2026-03-19 | Korean | ||
| 32983212 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-19 | Korean | ||
| 32969462 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-18 | Korean | ||
| 32960361 | 주식등의대량보유상황보고서(일반) | 2026-03-17 | Korean | ||
| 32928701 | 권리락 (무상증자) | 2026-03-11 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ARGENT BIOPHARMA LIMITED
Develops plant-inspired and synthetic medicines for neurolo…
|
RGT | AU | Manufacturing |
|
argenx SE
Develops and commercializes antibody-based therapies for se…
|
1AE | NL | Manufacturing |
|
Armata Pharmaceuticals, Inc.
Develops bacteriophage therapeutics for antibiotic-resistan…
|
ARMP | US | Manufacturing |
|
AroCell AB
Develops and markets in vitro diagnostic (IVD) tests for on…
|
AROC | SE | Manufacturing |
|
ArriVent BioPharma, Inc.
Clinical-stage biopharma developing oncology drugs for diff…
|
AVBP | US | Manufacturing |
|
ARROWHEAD PHARMACEUTICALS, INC.
Biotechnology company developing RNAi therapies to treat in…
|
ARWR | US | Manufacturing |
|
ARS Pharmaceuticals, Inc.
Develops and commercializes needle-free products for admini…
|
SPRY | US | Manufacturing |
|
ARTELO BIOSCIENCES, INC.
Clinical-stage biopharma developing therapeutics by modulat…
|
ARTL | US | Manufacturing |
|
Arura Pharma Inc
Diversified manufacturer and distributor in consumer goods …
|
— | CA | Manufacturing |
|
Ascelia Pharma
Biotechnology company developing and commercializing novel …
|
ACE | SE | Manufacturing |
HLB Therapeutics Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/15813/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=15813 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=15813 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=15813 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 15813}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for HLB Therapeutics Co.,Ltd. (id: 15813)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.